NASDAQ · Drug Manufacturers - General

Biogen Inc. (BIIB) Stock

$225.71 +3.33% NASDAQ: BIIB Healthcare

Valuation

MetricValue
Price$225.71
Market Cap$33.35B
P/E Ratio40.07
P/B Ratio1.78
P/S Ratio3.38
EPS (TTM)$0.00
52-Week High$230.26
52-Week Low$135.39
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE4.52%
ROA2.60%
ROCE4.52%
Gross Margin19.14%
Operating Margin19.14%
Net Margin8.39%
Debt/Equity0.44
Current Ratio2.68

Annual Financials (USD)

Metric20212022202320242025
Revenue$11.0B$10.2B$9.8B$9.7B$9.8B
Operating Profit$2.8B$2.9B$2.1B$2.5B$1.9B
Net Profit$1.6B$3.0B$1.2B$1.6B$1.3B
EPS$10.40$20.87$7.97$11.19$8.83
Op Margin25.4%28.4%21.3%25.7%19.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$23.9B$24.6B$26.8B$28.0B$29.4B
Total Liabilities$12.9B$11.2B$12.0B$11.3B$11.2B
Cash$2.3B$3.4B$1.1B$2.4B$3.0B
Borrowings$7.6B$6.6B$7.3B$6.6B$6.9B

Latest News

Acumen Pharmaceuticals Shows Early Alzheimer’s Disease Insights Exec Edge · Jul 15, 2026 Analyst Report: Ionis Pharmaceuticals, Inc. Morningstar Research · Jul 15, 2026 Analyst Report: Biogen Inc. Morningstar Research · Jul 15, 2026 3 Reasons to Avoid BIIB and 1 Stock to Buy Instead StockStory · Jul 15, 2026 Biogen Shares Decline After Detailed Diranersen Alzheimer's Study Data Zacks · Jul 15, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$3.6B$1.4B$1.5B$2.9B$2.2B
Investing Cash Flow$-822.0M$1.3B$-4.4B$-1.2B$-1.5B
Financing Cash Flow$-1.9B$-756.0M$-6.0M$-2.0M$-275.0M
Net Cash Flow$930.0M$1.2B$-2.4B$1.3B$634.0M
Free Cash Flow$3.4B$1.1B$1.2B$2.5B$2.1B

Valuation & Return Ratios

MetricValue
PEG Ratio-0.87
EV / EBITDA24.36
FCF Yield8.83%
Quick Ratio1.26
Interest Coverage4.47
Return 1Y50.87%
Return 3Y-14.55%
Return 5Y-23.61%

Ownership

Insiders Held0.19%
Institutions Held96.31%
Institutions Float Held96.49%
Institutional HolderSharesReport Date
Blackrock Inc.15,974,6012026-03-31
Primecap Management Company14,757,6072026-03-31
FMR, LLC12,807,5412026-03-31
Vanguard Capital Management LLC9,537,4172026-03-31
State Street Corporation7,167,9222026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ALNYAlnylam Pharmaceuticals, Inc. $232.68 +3.63% 36.02 $31.13B 0.00%
AMGNAmgen Inc. $414.87 +1.82% 25.56 $223.91B 2.43%
AZNAstraZeneca PLC $159.20 +0.26% 24.77 $246.90B 1.27%
IONSIonis Pharmaceuticals, Inc. $45.28 +4.57% -12.57 $7.52B 0.00%
LLYEli Lilly and Company $1179.27 +0.83% 39.60 $1.11T 0.58%

About Biogen Inc.

Biogen Inc. is led by CEO Christopher A. Viehbacher, employs 7,605 people, headquartered in Cambridge, US, publicly traded since 1991.

Biogen Inc. (BIIB) stock trades at $225.71 with a market capitalization of $33.35B. The stock is valued at a price-to-earnings (P/E) ratio of 40.07, price-to-book of 1.78, price-to-sales of 3.38. Over the past 52 weeks the stock has ranged between $135.39 and $230.26, and currently trades 2.0% below its 52-week high.

On profitability, Biogen Inc. generates a return on equity (ROE) of 4.52%, return on capital employed of 4.52%, an operating margin of 19.14%, a net profit margin of 8.39%.

In its most recent fiscal year, Biogen Inc. reported annual revenue of $9.8B, net profit of $1.3B, revenue has compounded at -6.1% a year over the last five years, profit at -20.2% a year.

The balance sheet shows a debt-to-equity ratio of 0.44 — a conservative balance sheet with little leverage risk, a current ratio of 2.68, total assets of $29.4B, $3.0B in cash and equivalents.

BIIB has a beta of 0.17 (less volatile than the overall market).

Related Healthcare Stocks

LLY Eli Lilly and Company $1179.27 +0.83% JNJ Johnson & Johnson $261.44 +1.93% ABBV AbbVie Inc. $276.47 +1.49% MRK Merck & Company, Inc. Common Stock (new) $145.60 +2.26% UNH UnitedHealth Group Incorporated Common Stock (DE) $379.30 +2.25% NVS Novartis AG $143.75 +0.45% AZN AstraZeneca PLC $159.20 +0.26% TMO Thermo Fisher Scientific Inc $658.02 +0.93% AMGN Amgen Inc. $414.87 +1.82% GILD Gilead Sciences, Inc. $151.17 +2.77% ABT Abbott Laboratories $99.60 +1.13% NVO Novo Nordisk A/S $38.64 +1.20%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides